International Journal of Pediatric Endocrinology · 2014 · 156 citations · 43 references
MedicineEndocrinologyGeneticsCytogeneticsReproductive EndocrinologyReproductive MedicineDisorders Of Sex DevelopmentGonadal DevelopmentGonadal DisordersGonadal EndocrinologySex Chromosome CytogeneticsSex Differentiation46, Xy Gonadal DysgenesisDiagnostic Follow-upDisorders Of Sexual DifferentiationEthical Considerations In ScreeningMalignancy Risk AssessmentSex Chromosome AbnormalitiesSexual Development AssessmentSexual Development Disruption
Gonadal dysgenesis, a disorder of sexual development with a spectrum from virilized to ambiguous phenotypes, poses diagnostic and management challenges, especially in XY patients who carry Y‑chromosome material and an elevated risk of gonadal malignancy, yet no consensus guidelines exist for risk assessment or gonadectomy timing. The authors aimed to review the literature and formulate evidence‑based guidelines for the diagnostic work‑up and management of XY gonadal dysgenesis. They conducted a systematic literature review and applied the GRADE framework to grade evidence and issue recommendations on diagnostic procedures, malignancy risk stratification, gonadectomy timing and necessity, biopsy role, and ethical considerations. Their recommendations provide clinicians with a structured, evidence‑based approach to diagnosing and managing XY gonadal dysgenesis.
Gonadal dysgenesis, a condition in which gonadal development is interrupted leading to gonadal dysfunction, is a unique subset of disorders of sexual development (DSD) that encompasses a wide spectrum of phenotypes ranging from normally virilized males to slightly undervirilized males, ambiguous phenotype, and normal phenotypic females. It presents specific challenges in diagnostic work-up and management. In XY gonadal dysgenesis, the presence of a Y chromosome or Y-chromosome material renders the patient at increased risk for developing gonadal malignancy. No universally accepted guidelines exist for identifying the risk of developing a malignancy or for determining either the timing or necessity of performing a gonadectomy in patients with XY gonadal dysgenesis. Our goal was to evaluate the literature and develop evidence-based medicine guidelines with respect to the diagnostic work-up and management of patients with XY gonadal dysgenesis. We reviewed the published literature and used the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) system when appropriate to grade the evidence and to provide recommendations for the diagnostic work-up, malignancy risk stratification, timing or necessity of gonadectomy, role of gonadal biopsy, and ethical considerations for performing a gonadectomy. Individualized health care is needed for patients with XY gonadal dysgenesis, and the decisions regarding gonadectomy should be tailored to each patient based on the underlying diagnosis and risk of malignancy. Our recommendations, based on the evidence available, add an important component to the diagnostic and management armament of physicians who treat patients with these conditions.
43
Grading quality of evidence and strength of recommendations
David C. Atkins, Dana Best, Peter A. Briss et al. · BMJ · 2004 · 8.5K citations · Full text
Consensus Statement on Management of Intersex Disorders
Peter A. Lee, Christopher P. Houk, S. Faisal Ahmed et al. · PEDIATRICS · 2006 · 2.3K citations